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Abstract 
Background: All suspected cases of malaria should receive a diagnostic test prior to treatment with artemisinin‑
based combinations based on the new WHO malaria treatment guidelines. This study compared the accuracy and 
some operational characteristics of 22 different immunochromatographic antigen capture point‑of‑ malaria tests 
(RDTs) in Cameroon to inform test procurement prior to deployment of artemisinin‑based combinations for malaria 
treatment.
Methods: One hundred human blood samples (50 positive and 50 negative) collected from consenting febrile 
patients in two health centres at Yaoundé were used for evaluation of the 22 RDTs categorized as “Pf Only” (9) or 
“Pf + PAN” (13) based on parasite antigen captured [histidine rich protein II (HRP2) or lactate dehydrogenase (pLDH) or 
aldolase]. RDTs were coded to blind technicians performing the tests. The sensitivity, specificity, and predictive values 
of the positive and negative tests (PPV and NPV) as well as the likelihood ratios were assessed. The reliability and some 
operational characteristics were determined as the mean values from two assessors, and the Cohen’s kappa statistic 
was then used to compare agreement. Light microscopy was the referent.
Results: Of all RDTs tested, 94.2 % (21/22) had sensitivity values greater than 90 % among which 14 (63.6 %) were 
‘Pf + PAN’ RDTs. The specificity was generally lower than the sensitivity for all RDTs and poorer for “Pf Only” RDTs. The 
predictive values and likelihood ratios were better for non‑HRP2 analytes for “Pf + PAN” RDTs. The Kappa value for 
most of the tests obtained was around 67 % (95 % CI 50–69 %), corresponding to a moderate agreement.
Conclusion: Overall, 94.2 % (21/22) of RDTs tested had accuracy within the range recommended by the WHO, 
while one performed poorly, below acceptable levels. Seven “Pf + PAN” and 3 “Pf Only” RDTs were selected for further 
assessment based on performance characteristics. Harmonizing RDT test presentation and procedures would prevent 
mistakes of test performance and interpretation.
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Background
The challenge of controlling malaria is a continuous 
reality in most sub-Saharan countries. Despite increas-
ing efforts in prevention and treatment, malaria has 
remained a major cause of morbidity and mortality, with 
an estimated 451 million clinical cases of malaria in 2007 
alone, mostly in sub-Saharan Africa [1]. In Cameroon, 
malaria continues to be endemic with estimated 71 % liv-
ing in high transmission areas [2], and the major cause 
of morbidity and mortality among the most vulnerable 
groups, namely children under 5 years of age and preg-
nant women, as well as the poor. The continuous exist-
ence of such huge burden due to malaria in 2010 has 
necessitated the implementation of large scale programs 
geared at eliminating malaria as a public health problem. 
Effective treatment of malaria requires precise labora-
tory diagnosis and this remains a cornerstone for global 
malaria control efforts. Microscopy still remains the 
method of choice in the diagnosis of malaria in endemic 
areas because it is cost effective. However correct iden-
tification of Plasmodium species by microscopy depends 
on factors, such as the experience of the microscopists, 
proper staining of the slides, good quality reagents, 
appropriate maintenance of the microscope and the time 
spent reading a slide. Due to these limitations, physi-
cians are often reluctant to accept results of microscopy 
in such operational settings. Therefore, the reliance of 
diagnosis on clinical grounds alone has resulted in over 
diagnosis of malaria in many clinical settings in develop-
ing countries including Cameroon [3–5]. Rapid diagnos-
tic tests have considerable potential as a tool to improve 
the diagnosis of malaria in endemic settings [5, 6]. Due to 
the rapidity of the test and availability of the results for 
clinical care, RDTs have been positively recommended 
by the World Health Organization (WHO) when reliable 
microscopy is not available [7].
There is increasing interest in introducing RDTs for 
diagnosing malaria and improving malaria case man-
agement with artemisinin-based combination therapy 
(ACT), as studies show significant improvements in 
malaria control following implementation [8]. In 2010, 
forty-two African countries reported deployment of 
11 million ACT at community level, with only a small 
proportion in the community receiving parasite confir-
mation test at community level [2]. Clearly, the WHO 
underscores the importance of expanding malaria diag-
nosis at community level as demonstrated in Zambia 
with scaling up of RDT use during the period 2004–
2009 [2]. The benefits of such a strategy include reduc-
tion in expenditures on anti-malarial drugs, improved 
patient outcomes for non-malarial fevers and curbing of 
drug resistance [15, 16]. The Government of Cameroon 
planned to introduce RDTs into communities in 50 pilot 
Health Districts in the national territory in 2011 as part 
of a Global Fund supported project for deploying ACT 
for case management at community level. However, there 
has been little or no previous report on the field perfor-
mance of different RDTs recommended by the WHO and 
available in the Cameroon market to properly inform 
procurement. It was, therefore, necessary to evaluate the 
performance of RDTs available in the Cameroon market. 
This study therefore aimed to determine and compare the 
diagnostic accuracy of 22 different rapid diagnostic tests 
available in Cameroon at that time.
Methods
Participants
The study population was made up of male and female 
febrile patients aged 1  year to 16  years suspected of a 
malaria infection in six busy peripheral health centres in 
Yaoundé. A patient was considered for enrolment into 
the study if he/she fulfilled the following criteria: willing-
ness to donate 5 mls of blood after informed consent. If 
the patient sample was positive by microscopy, consent/
assent was requested to participate. If the patient’s blood 
sample was negative by microscopy, the patient was still 
requested to consent. This procedure was followed con-
secutively until the required number of malaria positive 
and negative samples was obtained. Those performing 
the microscopy at the health centres were trained to col-
lect, prepare, read and quantify malaria smears by light 
microscopy.
Setting
Malaria transmission in Yaoundé is year round with four 
climatically distinct seasons composed of 2 short and two 
long dry and raining seasons respectively. Peak transmis-
sion occurs in the beginning of the rainy season. This 
assessment was conducted in April when transmission of 
malaria was expected to be at its peak.
Specimen collection
In each centre, 5 ml of whole blood was collected from 
consenting febrile patients by venous puncture into pre-
labelled EDTA tubes. For each blood specimen, about 
200 μl was used to prepare a thick film and a thin blood 
smear for malaria parasite density determination and 
speciation. Microscopy was used as the reference test. 
This test was chosen because it is considered as the refer-
ence method for malaria diagnosis by the WHO. Blood 
smears were stained with freshly prepared 3  % Giemsa 
solution according to standard procedures. To con-
firm microscopy diagnosis at the health centre, a new 
diagnosis was performed by two experienced and certi-
fied microscopists from the Biotechnology Centre and 
the Yaoundé University Teaching Hospital. They were 
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blinded to the health centre diagnosis. The thick smears 
were used to detect the presence of Plasmodium infec-
tion. The thin smears were considered negative if no 
parasite was seen in 100 oil-immersion fields from two 
independent readings. A third reading was performed in 
case of positive/negative discordance for asexual stages.
Rapid diagnostic tests
The RDTs in the study were obtained from major local 
distributors of clinical rapid diagnostic tests and other 
clinical laboratory suppliers in Cameroon. In total, 
twenty-two different RDTs used for malaria diagnosis 
and present in the market in 2010 were obtained. Selec-
tion of the RDTs was based on their presence in the Cam-
eroon market and distributor’s willingness to participate 
in the assessments. The test cassettes or strips were of 
traceable quality (standard supplier, used within the 
shelf life of the product). History of proper storage and 
transport conditions from manufacturers could not be 
guaranteed.
The technical specifications of the various RDTs are 
presented as supplemental material (Additional file  1). 
Nine of the RDT kits detect only Plasmodium falcipa-
rum, while the rest had detection analytes for P. falcipa-
rum and PAN representing other Plasmodium species. 
The test devices were mostly plastic lateral flow cassettes 
(18) and dipsticks (4). Most of the RDTs kits contained 
specimen transfer/reagent transfer devices except stated 
in the instructions to use a specific transfer device like a 
micropipette. Test antigens used in the kits were P. fal-
ciparum specific histidine rich protein II (HRP2), lactate 
dehydrogenase (LDH) and aldolase in order of frequency 
of occurrence in RDTs.
RDT test procedure and evaluating test results
Evaluation of the 22 RDTs was performed and interpreted 
according to the manufacturers’ instructions presented 
in the inserted inserts. Three technicians performed the 
tests. These technicians were not trained, but could inter-
pret the procedures stated in the insert. In the case where 
the procedure required prior preparation of reagents or 
the use of multiple devices, each procedure technician 
consistently performed the same task each time to ensure 
uniformity in test performance. They were blinded to 
each other’s results and to the results of microscopy. For 
each RDT the result was classified as negative, positive or 
invalid (Fig. 1). All tests without a control line were con-
sidered invalid by the test reader and the test repeated 
with a new RDT of the same code.
Assessment of ease of use and interpretation of RDTs
The study laboratory technicians who performed the 
RDTs ranked the 22 tests independently in order of pref-
erence where 2 corresponded to their most preferred 
1. Pf with or without PAN positive
2. No control, Invalid
3. Negative test result
4. Plasmodium positive, species other 
than Plasmodium falciparum
5. Invalid test result.
CPfPf±PAN
C= Control line, Pf : Plasmodium falciparum, Pf±PAN: Plasmodium falciparum with or 
without other malaria parasite species.
Fig. 1 Test line configuration for HRPII based RDTs used in our assessments and their interpretation. Line configurations differed slightly depend‑
ing on target antigen. In this study target antigens for RDTs included Plasmodium LDH, HRP2 and aldolase. Invalid test cassettes were noted and 
replaced during the assessments. C: Control line, Pf: Plasmodium falciparum, Pf + PAN: Plasmodium falciparum with or without other malaria parasite 
species
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test and “0” to their least preferred based on a question-
naire response on a Likert scale from 0(poor) to 3(good) 
to 5(best): Ease and safety of taking blood; ease of adding 
reagents including the complexity of material/handling/
transfer technique and device required and ease of inter-
pretation of insert instructions. In addition, assessors of 
RDT results were asked to rank the tests independently 
based ease of interpretation defined by the position of 
bands, labeling, band intensity, background and time to 
interpretation of results.
Sample size, data management and analysis
This assessment was a passive case detection survey. For 
malaria RDT under the study setting to perform well, 
the sensitivity should be at least 90 % and the specificity 
80  %. expert opinion was sought that indicated a likeli-
hood ratio of the positive test of at least 2 was clinically 
useful in ruling in malaria diagnosis with a good RDT. 
The likelihood ratio was used as our as our diagnostic test 
index because it does not change with pre-test probabil-
ity. Therefore the 95 % confidence interval to exclude the 
likelihood ratio estimate using the values of the param-
eters provided above (Sensitivity/1-specificity) was calcu-
lated. This is given by the expression
where P1 and P2 are sensitivity and (1-specificity) respec-
tively and n1 = n2 = sample size. In this way the sample 
size was estimated at 100.
The data was checked for inconsistencies in data entry 
such as missing values and then used to calculate the sen-
sitivity, specificity, the predictive values of the negative 
and positive RDT tests as well as the likelihood ratios and 
their 95 % confidence intervals. Inter-observer variations 
in the RDT test assessments were estimated by calculat-
ing for each operational parameter the Cohen’s kappa (κ) 
statistic as follows:
where A  =  agreement observed, B  =  agreement by 
chance = 50 % of times, C = agreement possible = 100 %.
A 95 % confidence interval (95 % CI) was calculated for 
each κ value and the overall agreement was evaluated as 
the weighted κ value with its 95 % confidence interval.
Ethics statement
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from routine medical exam were used provided verbal 
consent by phone. Information about the research was 
explained to each of one hundred participants/guardians 
by the consultant of the health centre either by phone or 
face to face for those who could come to the clinics. Par-
ticipation was entirely voluntary.
Results and discussion
Overall, each of 22 different RDTs were tested on a total 
of ninety-seven venous blood samples. Three of the RDT 
test types were dipsticks while the rest were strips in rec-
tangular cassettes.
Sensitivity, specificity and predictive values of the rapid 
tests
Results of the RDT evaluation are presented in Additional 
file 2. From this table, of all RDTs tested, (21/22) 95.4 % 
had sensitivity values greater than 90  % consistent with 
the WHO recommendations [7]. Among these RDTs with 
greater than 90 % sensitivity, 7/9 (77.8 %) were “Pf Only” 
RDTs while the rest (14/22; 63.6  %) were “Pf  +  PAN” 
RDTs. with sensitivity values greater than 90  % indicat-
ing that there seems to be more of highly performing “Pf 
Only” RDTs than “Pf  +  PAN” RDTs Furthermore, only 
6/13 (46.1 %) of “Pf + PAN” RDTs had sensitivity values 
less than 80 %. Two “Pf + PAN” RDTs had sensitivity less 
than 55  %. Considering specificity, only one “Pf Only” 
RDT had specificity greater than 90  %. The “Pf Only” 
RDTs had poor specificities with values around 60 %. On 
the other hand, only about 8 (36.3 %) “Pf + PAN” RDTs 
had sensitivity values greater than 90 %. Generally, RDTs 
with high sensitivity had low specificities and vice versa. 
A few RDTs (6/23 or 23 %) had sensitivities and specific-
ity values of at least 80 % and these were all “Pf + PAN” 
RDTs indicating that these RDT types seems to be bet-
ter in diagnosing malaria when it is important to know 
if other species are contributing to the infection. Among 
all RDT analytes, the pLDH consistently showed higher 
sensitivity and specificity compared to the pHRP2. The 
predictive values of the positive test were generally below 
80 % for 18 RDTs (78.2 %) among which only 2 were “Pf 
Only” RDTs. Of all RDTs tested, 11(47.8 %) had predic-
tive values of the negative test greater than 80 %. Of these 
11 RDTs, only one was a “Pf Only” RDT while among the 
“Pf + PAN” RDTs with greater than 80 % predictive value 
of the negative test, only 1(7.6 %) was represented by the 
pHRP2 analyte, comparing pHRP2 and pLDH/pAldo-
lase on the “Pf + PAN” RDTs. This indicates that on the 
“Pf + PAN” RDTs, the PAN analyte on “Pf + PAN” RDTs 
seems to be better in excluding infections with P. falcipa-
rum compared to pfHRP2 on the same RDTs.
The majority of RDTs with good sensitivity had speci-
ficity less than 75 %. Only 6/14 or 42 % had sensitivity 
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and specificity values greater than 80  %. Even though 
the sensitivity of an RDT is most often considered as the 
key parameter in clinical case management in malaria, 
it is desirable that the test analyte detects the antigens 
for which it is intended. One of the challenges associ-
ated with the use of RDTs is cross reactivity with anti-
gens of a similar nature but from a different source 
[18]. Arguably, that the use of RDTs in case manage-
ment provides added benefit of identifying patients who 
would otherwise have been missed if diagnosis relied on 
microscopy alone [19] eliminating the problem of over-
diagnosis. Indeed, a recent exit poll involving malaria 
treated patients in Cameroon observed that over 50  % 
of patients were overtreated for malaria [5]. It is impor-
tant that the RDTs used for widespread identification 
of malaria patients within integrated programmes have 
good specificity values to avoid a negative impact of the 
implemented RDT for facility and community manage-
ment of fevers.
Performance of analytes in RDTs
Tests that target HRP of P. falciparum demonstrated 
higher parasite detection rates compared to other ana-
lytes among all RDTs in this evaluation. However, tests 
that target LDH performed better when comparing both 
sensitivity and specificity for “Pf  +  PAN” RDTs. These 
findings are in agreement with the WHO based evalua-
tion of RDTs for informed recommendations [7]. There-
fore, tests that target HRP2 present in “Pf Only” RDTs 
appear to be better suited for the purpose of detecting 
the majority of malaria infections in the community. 
Furthermore, tests that were PAN specific had better 
predictive values of the positive and negative tests as 
well as the likelihood ratios of positive and negative tests 
compared to tests that detected HRP2 only. In the case 
where the additional objective would be to identify the 
presence of other species of parasites, test systems that 
include pLDH in association with HRP2 in this evalua-
tion will be preferable. Plasmodium falciparum is the 
dominant species in our geo-ecological settings, but 
mixed parasite populations have been observed previ-
ously by our group to be circulating in some regions. In 
Bangolan, NW Cameroon where this observation was 
made, infections either consisted of P. falciparum coex-
isting with Plasmodium malariae (in 70  % of cases) or 
non-P. falciparum (P. malariae in 30  % of cases) [23]. 
Therefore, using a “Pf Only” RDT based on detection of 
HRP2 will miss 30  % of single infections with non-fal-
ciparum parasites. In addition, there is the possibility of 
gene deletion isolates that do not express HRP-2 [20], 
although it has not been examined among parasite iso-
lates from Cameroon and the same evidence for pLDH 
has not yet been found.
Rapid diagnostic test agreement
The weighted agreement between the two observ-
ers involved in reading the RDT results was quanti-
fied as the weighted Kappa value calculated for all test 
results irrespective of whether the test was a “Pf Only” 
or “Pf  +  PAN” RDT type. The weighted Kappa value 
obtained was 67.5 % (95 % CI 64.6–70.3 %), correspond-
ing to a moderately agreement between the assessors 
under our field condition. However, the agreements were 
better for some tests over others. For example, good 
agreement was obtained for more “Pf + PAN” RDTs than 
for “Pf Only” RDTs. SD Bioline Pf +  PAN test cassette 
had the best agreement (72.6, 95 % CI 58.9.6–86.4), based 
on the detection of both Pf and PAN while Clearview 
Malaria Combo was worst (54.9, 95 % CI 38.8–71.2).
Operational characteristics
Based on the assessment of operational and technical 
characteristics of the 22 RDTs, differences in the test 
presentation, package contents, blood lancing and trans-
fer devices, variations in insert instructions of use and 
safety disposal, procedures for test performance and 
results interpretation were observed. Additional file  3 
provides a classification fo RDTs based on some opera-
tional characteristics. With the plethora of RDT tests 
commercially available today, even tests pre-qualified 
by the WHO and used in this assessment are very dif-
ferent in terms of their presentation, increasing the risk 
of error by the end user. Challenges ranging from the 
quality of information in inserts, configuration of test 
and control lines, missing information or components 
in the test kit, etc. all pose serious deficits that adversely 
influence the performance of RDTs at point of care and 
have also been reported recently [22]. Therefore, it is 
highly recommended that while efforts are being made 
to increase access of RDTs at the point of care, finding a 
way of providing a simple, informed and systematic pres-
entation guideline and test to be followed by manufac-
turers of malaria RDTs destined for endemic countries is 
important.
Because of the free distribution of long-lasting insecti-
cide-treated bed nets since 2011 to almost every house-
hold in Cameroon, a rapid decrease in the prevalence 
of malaria in many areas in Cameroon is expected. Low 
intensity infections may pose a diagnostic challenge for 
malaria surveillance purposes in the future due to shift-
ing disease control priority, necessitating nucleic acid 
based tests.
Study limitations
This study has several potential limitations. Firstly, the 
results of rapid diagnostic tests vary as a function of par-
asite density [18]. It would have been valuable to classify 
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RDTs based on parasite density to better compare results 
with the WHO standards. In addition, the results also 
assumed manufacturer reported stability. The present 
assessments were performed during a season when the 
minimal temperature in Yaoundé varied between 25 and 
29  °C. Further studies in which difference RDT perfor-
mances will be compared in different real life environmen-
tal conditions will be very helpful to evaluate other stability 
parameters affecting the performance and decay of RDTs.
Conclusion
Of all RDTs tested, 94.2  % (21/22) had sensitivity val-
ues greater than 90  % among which 14 (63.6  %) were 
‘Pf  +  PAN’ RDTs. The specificity was generally lower 
than the sensitivity for all RDTs, and poorer for “Pf Only” 
RDTs. The predictive values and likelihood ratios were 
better for non-HRP2 analytes for “Pf  +  PAN” RDTs. 
Rapid diagnostic tests which incorporate histidine rich 
protein II and lactate dehydrogenase are appropriate for 
settings. There was moderate agreement that SD Bio-
line Malaria Antigen P.f/Pan, ACON Malaria P.f/pan and 
Parascreen pf  +  PAN and CareStart™ Malaria HRP2/
pLDH Combo Test were most preferred in order of merit 
among “Pf + PAN” RDTs while SD Bioline Malaria Anti-
gen P.f and ParaHIT® pf HRPII the most preferred among 
“Pf Only” RDTs. Among the dipsticks, “Pf + PAN” Para-
HIT Total Dipstick was preferred. Harmonizing RDT test 
presentation and procedures would prevent mistakes of 
test performance and interpretation.
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